The genetic polymorphism of IRS-1 leads to reduced IRS-1 expression, resulting in an increased visceral fat-to-subcutaneous fat ratio, insulin resistance, hyperlipemia, and decreased adiponectin levels [153]. This evidence concerns the gene IRS1 and familial hyperlipidemia.